menu
techminis

A naukri.com initiative

google-web-stories
Home

>

Bio News

>

Research R...
source image

Bioengineer

2d

read

297

img
dot

Image Credit: Bioengineer

Research Reveals That Loss of Y Chromosome in Blood Cells Impairs Immune Defense Against Cancer

  • A study led by researchers at the University of Arizona Comprehensive Cancer Center reveals that the loss of the Y chromosome in male immune cells impairs immune function and may explain lower cancer survival rates in men.
  • The research, published in Nature, delves into the phenomenon of 'loss of Y' (LOY) in immune cells, particularly T lymphocytes, and its impact on cancer immunosurveillance.
  • LOY in white blood cells weakens the cytotoxic response of T cells, hindering their ability to identify and destroy cancer cells effectively.
  • The study found that LOY is not limited to malignant epithelial cells but also affects surrounding noncancerous components, suggesting a systemic influence on cancer pathogenesis.
  • T cells lacking the Y chromosome exhibit compromised functional capacities, enabling tumors to evade immune detection and facilitate disease progression.
  • Men with LOY in both cancerous cells and T cells tend to have more aggressive cancers and lower survival rates, emphasizing the synergistic impact of chromosomal aberrations.
  • The findings urge pre-treatment screening of patient-derived immune cells for LOY to optimize therapeutic outcomes, especially in immunotherapies like CAR T cell therapy.
  • Dr. Dan Theodorescu and Dr. Simon Knott spearheaded the study, shedding light on the intersection of chromosomal loss, immune function, and cancer prognosis.
  • The research not only advances cancer biology but also paves the way for personalized medicine strategies targeting male-specific vulnerabilities in cancer biology.
  • Genomic sequencing techniques were used to identify LOY-related changes in immune cells, providing insights into the molecular basis of immune dysfunction associated with LOY.
  • The study's implications extend beyond oncology, offering promise for understanding immune dysfunction in other age-related diseases, with potential for broader biomedical applications.

Read Full Article

like

17 Likes

For uninterrupted reading, download the app